VI
DGX icon

Versor Investments’s Quest Diagnostics DGX Stock Holding History

Versor Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,482
Closed -$951K – 194
2025
Q4 		$951K Sell
5,482
-904
-14% -$165K 0.15% 150
2025
Q3 		$1.22M Buy
6,386
+4,248
+199% +$754K 0.22% 70
2025
Q2 		$384K Sell
2,138
-5,275
-71% -$916K 0.07% 464
2025
Q1 		$1.25M Buy
7,413
+3,013
+68% +$495K 0.2% 135
2024
Q4 		$664K Sell
4,400
-1,897
-30% -$295K 0.11% 281
2024
Q3 		$978K Buy
6,297
+3,583
+132% +$535K 0.15% 199
2024
Q2 		$371K Sell
2,714
-7,634
-74% -$1.05M 0.07% 447
2024
Q1 		$1.38M Buy
+10,348
New +$1.34M 0.28% 71
2023
Q2 		– Sell
-3,600
Closed -$509K – 677
2023
Q1 		$509K Sell
3,600
-1,200
-25% -$172K 0.07% 321
2022
Q4 		$751K Buy
+4,800
New +$690K 0.06% 222
2021
Q4 		– Sell
-1,659
Closed -$241K – 561
2021
Q3 		$241K Buy
+1,659
New +$243K 0.01% 437
2020
Q2 		– Sell
-6,200
Closed -$498K – 228
2020
Q1 		$498K Buy
+6,200
New +$642K 0.03% 109

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Versor Investments's DGX Position: Q1 2026 in Review

Versor Investments sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 5,482 shares — an estimated $951K sold.

Versor Investments first reported a position in DGX in Q1 2020 and held it in 12 quarters. The position peaked at $1.38M in Q1 2024. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Versor Investments reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 5,482 Quest Diagnostics shares in Q1 2026, an estimated $951K.
  • Versor Investments first reported a position in Quest Diagnostics in Q1 2020 and held it in 12 quarters.
  • Versor Investments's Quest Diagnostics position peaked at $1.38M in Q1 2024.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.